Vanlent Anne is a director of Trevi Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Trevi Therapeutics, Inc.
30 Jun 23
3
ObsEva SA
3 Jan 23
4
APPLIED GENETIC TECHNOLOGIES CORP
1 Dec 22
4/A
Trevi Therapeutics, Inc.
1 Jul 22
4
Trevi Therapeutics, Inc.
23 Jun 22
4
APPLIED GENETIC TECHNOLOGIES CORP
2 Dec 21
4
Trevi Therapeutics, Inc.
17 Jun 21
4
APPLIED GENETIC TECHNOLOGIES CORP
18 Dec 20
4
Trevi Therapeutics, Inc.
15 Jun 20
4
APPLIED GENETIC TECHNOLOGIES CORP
6 Dec 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jun 23 | TRVI Trevi Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 2.27 | 30,000 | 68.10 k | 30,000 |